MedPath

Lidocaine and Prilocaine

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP

Approved
Approval ID

973d188e-8e96-4e7d-b94f-0349ca19cfe8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2023

Manufacturers
FDA

Rhodes Pharmaceuticals L.P.

DUNS: 831928986

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine and Prilocaine

PRODUCT DETAILS

NDC Product Code42858-029
Application NumberANDA213253
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateMarch 24, 2023
Generic NameLidocaine and Prilocaine

INGREDIENTS (6)

LidocaineActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PrilocaineActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
PEG-54 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine and Prilocaine - FDA Drug Approval Details